Abstract
To elucidate the molecular mechanisms for the enhancement of heat-induced apoptosis on exposure to acidic conditions, human maxillary carcinoma IMC-3 cells were heat-shocked at 44°C for 30 min at either pH 7.4 or 6.7. Analyses with cDNA arrays, the reverse transcription–polymerase chain reaction (RT–PCR), and Western blotting were performed. We found that histone deacetylase 3 (HDAC3) was specifically induced after hyperthermia at 44°C for 30 min at pH 6.7. Although the cytotoxicity of heating at 44°C for 30 min was enhanced by decreasing the pH from 7.4 to 6.7, it was enhanced even more by antisense RNA oligonucleotides for HDAC3. The induction of G2/M arrest after heating occurred earlier at pH 6.7 than at pH 7.4. The inhibition of HDAC3 by the antisense RNA oligonucleotides suppressed partially the induction of G2/M arrest, resulting in an enhancement of the apoptosis caused by the heating under acidic conditions. Antisense RNA oligonucleotides for HDAC3 enhanced apoptosis 48 h after hyperthermia at 43°C for 30 min in vivo. Analyses of p65 activity suggested that NF-κB is involved in this enhancement of hyperthermia. HDAC3 may be a novel target enhancing hyperthermia and combined treatment with hyperthermia and HDAC inhibitors is a possible modality for cancer therapy.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bakin RE and Jung MO . (2004). J. Biol. Chem., 279, 51218–51225.
Chen Lf, Fischle W, Verdin E and Greene WC . (2001). Science, 293, 1653–1657.
Cleveland JL, Troppmair J, Packham G, Askew DS, Lloyd P, Gonzalez-Garcia M, Nunez G, Ihle JN and Rapp UR . (1994). Oncogene, 9, 2217–2226.
Dahl O and Mella O . (2002). Int. J. Hyperther., 18, 25–30.
Engin K, Leeper DB, Tupchong L and Waterman FM . (1995). Clin. Cancer Res., 1, 139–145.
Fujieda S, Zhang K and Saxon A . (1995). J. Immunol., 155, 2318–2328.
Gan Y, Shen YH, Wang J, Wang X, Utama B, Wang J and Wang XL . (2005). J. Biol. Chem., 280, 16467–16475.
Gatenby RA and Gillies RJ . (2004). Nat. Rev. Cancer, 4, 891–899.
Glaser KB, Li J, Staver MJ, Wei RQ, Albert DH and Davidsen SK . (2003). Biochem. Biophys. Res. Commun., 310, 529–536.
Harmon BV, Corder AM, Collins RJ, Gobe GC, Allen J, Allan DJ and Kerr JF . (1990). Int. J. Radiat. Biol., 58, 845–858.
Huang Y, Tan M, Gosink M, Wang KK and Sun Y . (2002). Cancer Res., 62, 2913–2922.
Jin ZH, Matsumoto H, Hayashi S, Hatashita M, Ohtsubo T, Shioura H, Kitai R and Kano E . (2004). Int. J. Radiat. Oncol. Biol. Phys., 59, 852–860.
Khochbin S, Verdel A, Lemercier C and Seigneurin-Berny D . (2001). Curr. Opin. Genet. Dev., 11, 162–166.
Kiernan R, Bres V, Ng RW, Coudart MP, El Messaoudi S, Sardet C, Jin DY, Emiliani S and Benkirane M . (2003). J. Biol. Chem., 278, 2758–2766.
Levenson VV, Davidovich IA and Roninson IB . (2000). Cancer Res., 60, 5027–5030.
Liu F, Dowling M, Yang XJ and Kao GD . (2004). J. Biol. Chem., 279, 34537–34546.
Marshall JL, Rizvi N, Kauh J, Dahut W, Figuera M, Kang MH, Figg WD, Wainer I, Chaissang C, Li MZ and Hawkins MJ . (2002). J. Exp. Ther. Oncol., 2, 325–332.
Matsumoto H, Hayashi S, Hatashita M, Ohnishi K, Ohtsubo T, Kitai R, Shioura H, Ohnishi T and Kano E . (1999). Cancer Res., 59, 3239–3244.
Matsumoto H, Hayashi S, Shioura H, Ohtsubo T, Kitai R, Ohnishi K, Hayashi N, Ohnishi T and Kano E . (1998a). Int. J. Radiat. Oncol. Biol. Phys., 41, 915–920.
Matsumoto H, Hayashi S, Shioura H, Ohtsubo T, Nishida T, Kitai R, Ohnishi T and Kano E . (1998b). Int. J. Oncol., 13, 741–747.
Matsumoto H, Takahashi A, Wang X, Ohnishi K and Ohnishi T . (1997). Int. J. Radiat. Oncol. Biol. Phys., 38, 1089–1095.
Mizoguchi H, Komiyama S, Matsui K, Hamanaka R, Ono M and Kiue A . (1991). Int. J. Cancer., 49, 738–743.
Moroni MC, Willingham MC and Beguinot L . (1992). J. Biol. Chem., 267, 2714–2722.
Mukhopadhyay T and Roth JA . (1996). Crit. Rev. Oncog., 7, 151–190.
Murata M, Towatari M, Kosugi H, Tanimoto M, Ueda R, Saito H and Naoe T . (2000). Jpn. J. Cancer Res., 91, 1154–1160.
Narita N, Noda I, Ohtsubo T, Fujieda S, Tokuriki M, Saito T and Saito H . (2002). Int. J. Radiat. Oncol. Biol. Phys., 53, 190–196.
Ohnishi K and Ohnishi T . (2001). Int. J. Hyperther., 17, 415–427.
Ohtsubo T, Igawa H, Saito T, Matsumoto H, Park HJ, Song CW, Kano E and Saito H . (2001). Int. J. Radiat. Oncol. Biol. Phys., 49, 1391–1398.
Ohtsubo T, Park HJ, Lyons JC, Ohnishi T and Song CW . (2000). Int. J. Hyperther., 16, 481–491.
Overgaard J, Gonzalez Gonzalez D, Hulshof MC, Arcangeli G, Dahl O, Mella O and Bentzen SM . (1995). Lancet, 345, 540–543.
Park HJ, Lyons JC, Ohtsubo T and Song CW . (1999). Br. J. Cancer, 80, 1892–1897.
Pena LA, Fuks Z and Kolesnick R . (1997). Biochem. Pharmacol., 53, 615–621.
Rhee JG, Kim TH, Levitt SH and Song CW . (1984). Int. J. Radiat. Oncol. Biol. Phys., 10, 393–399.
Ru K, Schmitt S, James WI and Wang JH . (1999). Oncol. Res., 11, 505–512.
Sasakawa Y, Naoe Y, Inoue T, Sasakawa T, Matsuo M, Manda T and Mutoh S . (2002). Biochem. Pharmacol., 64, 1079–1090.
Sneed PK, Stauffer PR, McDermott MW, Diederich CJ, Lamborn KR, Prados MD, Chang S, Weaver KA, Spry L, Malec MK, Lamb SA, Voss B, Davis RL, Wara WM, Larson DA, Phillips TL and Gutin PH . (1998). Int. J. Radiat. Oncol. Biol. Phys., 40, 287–295.
Sugimoto C, Fujieda S, Seki M, Sunaga H, Fan GK, Tsuzuki H, Borner C, Saito H and Matsukawa S . (1999). Int. J. Cancer, 82, 860–867.
Takahashi A, Ota I, Tamamoto T, Asakawa I, Nagata Y, Nakagawa H, Kondo N, Ohnishi K, Furusawa Y, Matsumoto H and Ohnishi T . (2003). Int. J. Hyperther., 19, 145–153.
Takahashi I, Emi Y, Hasuda S, Kakeji Y, Maehara Y and Sugimachi K . (2002). Surgery, 131, 78–84.
Takasu T, Lyons JC, Park HJ and Song CW . (1998). Cancer Res., 58, 2504–2508.
Xia Z, Dickens M, Raingeaud J, Davis RJ and Greenberg ME . (1995). Science, 270, 1326–1331.
Yang WM, Yao YL, Sun JM, Davie JR and Seto E . (1997). J. Biol. Chem., 272, 28001–28007.
Yu X, Guo ZS, Marcu MG, Neckers L, Nguyen DM, Chen GA and Schrump DSJ . (2002). Natl. Cancer Inst., 94, 504–513.
Acknowledgements
This study was supported by a Grant-in-Aid for Scientific Research and Scientific Research on Priority Area (C) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. We thank Drs C Sugimoto, H Sunaga, H Igawa, Y Kimura and H Yamamoto (Department of Otorhinolaryngology, Fukui Medical University) for a critical review of this study. We are also grateful to Ms Kazumi Uno for excellent technical assistance.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Narita, N., Fujieda, S., Tokuriki, M. et al. Inhibition of histone deacetylase 3 stimulates apoptosis induced by heat shock under acidic conditions in human maxillary cancer. Oncogene 24, 7346–7354 (2005). https://doi.org/10.1038/sj.onc.1208879
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1208879
Keywords
This article is cited by
-
Targeting histone deacetylase-3 blocked epithelial-mesenchymal plasticity and metastatic dissemination in gastric cancer
Cell Biology and Toxicology (2023)
-
Histone deacetylase 3 (HDAC3) as an important epigenetic regulator of kidney diseases
Journal of Molecular Medicine (2022)
-
PIWIL2 suppresses Siah2-mediated degradation of HDAC3 and facilitates CK2α-mediated HDAC3 phosphorylation
Cell Death & Disease (2018)
-
HDAC3 Is Required for Posterior Lateral Line Development in Zebrafish
Molecular Neurobiology (2016)
-
Suppression of Poly(rC)-Binding Protein 4 (PCBP4) reduced cisplatin resistance in human maxillary cancer cells
Scientific Reports (2015)